Literature DB >> 8855514

Amphetamine-induced c-fos mRNA expression is altered in rats with neonatal ventral hippocampal damage.

S M Lillrank1, B K Lipska, S E Bachus, G K Wood, D R Weinberger.   

Abstract

To further characterize the mechanisms underlying enhanced dopamine-related behaviors expressed during adulthood in rats with neonatal excitotoxic ventral hippocampal (VH) damage, we studied the expression of c-fos mRNA in these rats after a single saline or amphetamine (AMPH) (10 mg/kg, i.p.) injection using in situ hybridization. The VH of rat pups was lesioned with ibotenic acid on postnatal day 7 (PD7). At the age of 90 days, rats were challenged with AMPH or saline, and the expression of c-fos mRNA using an oligonucleotide probe was assessed 30, 90, and 180 min later. AMPH significantly increased c-fos mRNA expression in medial prefrontal cortex, piriform cortex, cingulate cortex, septal region, and dorsolateral and ventromedial striatum in control and lesioned rats. However, this response to AMPH was attenuated 30 min after AMPH injection in all of these regions in the lesioned as compared to the sham-operated rats. No significant changes were seen at other time points. These results indicate that the neonatal VH lesion alters time-dependent intracellular signal transduction mechanisms measured by AMPH-induced c-fos mRNA expression in cortical and subcortical brain regions. Changes in c-fos mRNA expression in this putative animal model of schizophrenia may have implications for long-term alterations in cellular phenotype because of altered regulation of certain target genes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8855514     DOI: 10.1002/(SICI)1098-2396(199608)23:4<292::AID-SYN7>3.0.CO;2-2

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  8 in total

1.  Motivational responses to natural and drug rewards in rats with neonatal ventral hippocampal lesions: an animal model of dual diagnosis schizophrenia.

Authors:  R Andrew Chambers; David W Self
Journal:  Neuropsychopharmacology       Date:  2002-12       Impact factor: 7.853

2.  Testing the validity of c-fos expression profiling to aid the therapeutic classification of psychoactive drugs.

Authors:  B E H Sumner; L A Cruise; D A Slattery; D R Hill; M Shahid; B Henry
Journal:  Psychopharmacology (Berl)       Date:  2003-09-10       Impact factor: 4.530

3.  Animal Modeling and Neurocircuitry of Dual Diagnosis.

Authors:  R Andrew Chambers
Journal:  J Dual Diagn       Date:  2007-03

Review 4.  Schizophrenia: an integrative approach to modelling a complex disorder.

Authors:  George S Robertson; Sarah E Hori; Kelly J Powell
Journal:  J Psychiatry Neurosci       Date:  2006-05       Impact factor: 6.186

Review 5.  A scale-free systems theory of motivation and addiction.

Authors:  R Andrew Chambers; Warren K Bickel; Marc N Potenza
Journal:  Neurosci Biobehav Rev       Date:  2007-05-03       Impact factor: 8.989

6.  Emergence of stereotypies in juvenile monkeys (Macaca mulatta) with neonatal amygdala or hippocampus lesions.

Authors:  M D Bauman; J E Toscano; B A Babineau; W A Mason; D G Amaral
Journal:  Behav Neurosci       Date:  2008-10       Impact factor: 1.912

7.  Upregulation of Npas4 protein expression by chronic administration of amphetamine in rat nucleus accumbens in vivo.

Authors:  Ming-Lei Guo; Bing Xue; Dao-Zhong Jin; Zhen-Guo Liu; Eugene E Fibuch; Li-Min Mao; John Q Wang
Journal:  Neurosci Lett       Date:  2012-08-03       Impact factor: 3.046

8.  Enhanced methamphetamine self-administration in a neurodevelopmental rat model of schizophrenia.

Authors:  Anne Marie Brady; Sarah E McCallum; Stanley D Glick; Patricio O'Donnell
Journal:  Psychopharmacology (Berl)       Date:  2008-05-26       Impact factor: 4.530

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.